Skip to main content
. 2019 Oct 24;23(6):475–482. doi: 10.4196/kjpp.2019.23.6.475

Fig. 5. A diagram summarizing the main findings of this study.

Fig. 5

FoxD2-AS1 contributes to temozolomide (TMZ) resistance of glioma cells by regulating the methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter region.